The Role of Kynurenine and Its Metabolites in Comorbid Chronic Pain and Depression
Chronic pain and depression affect millions of people worldwide, and their comorbidity tends to exacerbate the severity of each individual condition. Intersecting brain regions and molecular pathways could probably explain the unique yet complex bidirectional relationship between these two disorders...
Main Authors: | Onella Athnaiel, Charmaine Ong, Nebojsa Nick Knezevic |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-10-01
|
Series: | Metabolites |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-1989/12/10/950 |
Similar Items
-
Kynurenine Pathway Metabolites as Potential Biomarkers in Chronic Pain
by: Andrew Auyeung, et al.
Published: (2023-05-01) -
The Metabolic Factor Kynurenic Acid of Kynurenine Pathway Predicts Major Depressive Disorder
by: Hongye Liu, et al.
Published: (2018-11-01) -
Research progress on the kynurenine pathway in the prevention and treatment of Parkinson’s disease
by: Ping Chen, et al.
Published: (2023-12-01) -
Systematic Review on the Involvement of the Kynurenine Pathway in Stroke: Pre-clinical and Clinical Evidence
by: Gabriela D. Colpo, et al.
Published: (2019-07-01) -
Twelve-week physical exercise does not have a long-lasting effect on kynurenines in plasma of depressed patients
by: Millischer V, et al.
Published: (2017-03-01)